This Insmed Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Monday

Wolfe Research analyst Andy Chen downgraded Insmed Inc (NASDAQ: INSM) from Outperform to Peer Perform, with shares closing at $100.60 on Friday. This downgrade is part of a broader trend, as several analysts have adjusted their ratings on various companies. The article highlights that Insmed is among the top five downgrades for the day.